| SC 13G/A | 2017-02-13 | Capital World Investors | ChemoCentryx, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2017-02-10 | WASATCH ADVISORS INC | ChemoCentryx, Inc. | - | - | EDGAR |
| SC 13D/A | 2016-08-25 | GLAXOSMITHKLINE PLC | ChemoCentryx, Inc. | 7,343,492 | 15.4% | EDGAR |
| SC 13G | 2016-05-23 | Vifor (International) Ltd | ChemoCentryx, Inc. | 3,333,333 | 7.0% | EDGAR |
| SC 13G/A | 2016-02-16 | WASATCH ADVISORS INC | ChemoCentryx, Inc. | - | - | EDGAR |
| SC 13G/A | 2016-02-16 | BALYASNY ASSET MANAGEMENT LLC | ChemoCentryx, Inc. | 607,932 | 1.4% | EDGAR |
| SC 13G/A | 2016-02-12 | Schall Thomas J. | ChemoCentryx, Inc. | 4,014,430 | 8.7% | EDGAR |
| SC 13G/A | 2016-02-12 | Capital World Investors | ChemoCentryx, Inc. | 3,467,240 | 7.9% | EDGAR |
| SC 13G/A | 2016-02-05 | BIOTECHNOLOGY VALUE FUND L P | ChemoCentryx, Inc. | 2,472,477 | 5.6% | EDGAR |
| SC 13G | 2015-11-13 | SAMANA CAPITAL, L.P. | ChemoCentryx, Inc. | 28,881 | 0.1% | EDGAR |
| SC 13G/A | 2015-11-09 | BIOTECHNOLOGY VALUE FUND L P | ChemoCentryx, Inc. | 2,162,381 | 4.9% | EDGAR |
| SC 13G | 2015-06-30 | BALYASNY ASSET MANAGEMENT LLC | ChemoCentryx, Inc. | 933,797 | 2.1% | EDGAR |
| SC 13G/A | 2015-02-17 | WASATCH ADVISORS INC | ChemoCentryx, Inc. | - | - | EDGAR |
| SC 13G/A | 2015-02-17 | BIOTECHNOLOGY VALUE FUND L P | ChemoCentryx, Inc. | 2,162,381 | 5.0% | EDGAR |
| SC 13G/A | 2015-02-17 | Schall Thomas J. | ChemoCentryx, Inc. | 3,764,140 | 8.4% | EDGAR |
| SC 13G/A | 2015-02-13 | BALYASNY ASSET MANAGEMENT LLC | ChemoCentryx, Inc. | 885,126 | 2.0% | EDGAR |
| SC 13G/A | 2015-02-13 | Capital World Investors | ChemoCentryx, Inc. | 3,467,240 | 7.9% | EDGAR |
| SC 13G | 2014-06-02 | BALYASNY ASSET MANAGEMENT LLC | ChemoCentryx, Inc. | 1,193,787 | 2.8% | EDGAR |
| SC 13G/A | 2014-02-14 | BIOTECHNOLOGY VALUE FUND L P | ChemoCentryx, Inc. | 2,162,381 | 5.0% | EDGAR |
| SC 13G/A | 2014-02-14 | RA CAPITAL MANAGEMENT, LLC | ChemoCentryx, Inc. | 0 | 0.0% | EDGAR |